TY - JOUR
T1 - Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells
AU - Shojima, Nobuhiro
AU - Sakoda, Hideyuki
AU - Ogihara, Takehide
AU - Fujishiro, Midori
AU - Katagiri, Hideki
AU - Anai, Motonobu
AU - Onishi, Yukiko
AU - Ono, Hiraku
AU - Inukai, Kouichi
AU - Abe, Miho
AU - Fukushima, Yasushi
AU - Kikuchi, Masatoshi
AU - Oka, Yoshitomo
AU - Asano, Tomoichiro
PY - 2002
Y1 - 2002
N2 - Resistin is a hormone secreted by adipocytes that acts on skeletal muscle myocytes, hepatocytes, and adipocytes themselves, reducing their sensitivity to insulin. In the present study, we investigated how the expression of resistin is affected by glucose and by mediators known to affect insulin sensitivity, including insulin, dexamethasone tumor necrosis factor-α (TNF-α), epinephrine, and somatropin. We found that resistin expression in 3T3-L1 adipocytes was significantly upregulated by high glucose concentrations and was suppressed by insulin. Dexamethasone increased expression of both resistin mRNA and protein 2.5- to 3.5-fold in 3T3-L1 adipocytes and by ∼70% in white adipose tissue from mice. In contrast, treatment with troglitazone, a thiazolidinedione antihyperglycemic agent, or TNF-α suppressed resistin expression by ∼80%. Epinephrine and somatropin were both moderately inhibitory, reducing expression of both the transcript and the protein by 30-50% in 3T3-L1 adipocytes. Taken together, these data make it clear that resistin expression is regulated by a variety of hormones and that cytokines are related to glucose metabolism. Furthermore, they suggest that these factors affect insulin sensitivity and fat tissue mass in part by altering the expression and eventual secretion of resistin from adipose cells.
AB - Resistin is a hormone secreted by adipocytes that acts on skeletal muscle myocytes, hepatocytes, and adipocytes themselves, reducing their sensitivity to insulin. In the present study, we investigated how the expression of resistin is affected by glucose and by mediators known to affect insulin sensitivity, including insulin, dexamethasone tumor necrosis factor-α (TNF-α), epinephrine, and somatropin. We found that resistin expression in 3T3-L1 adipocytes was significantly upregulated by high glucose concentrations and was suppressed by insulin. Dexamethasone increased expression of both resistin mRNA and protein 2.5- to 3.5-fold in 3T3-L1 adipocytes and by ∼70% in white adipose tissue from mice. In contrast, treatment with troglitazone, a thiazolidinedione antihyperglycemic agent, or TNF-α suppressed resistin expression by ∼80%. Epinephrine and somatropin were both moderately inhibitory, reducing expression of both the transcript and the protein by 30-50% in 3T3-L1 adipocytes. Taken together, these data make it clear that resistin expression is regulated by a variety of hormones and that cytokines are related to glucose metabolism. Furthermore, they suggest that these factors affect insulin sensitivity and fat tissue mass in part by altering the expression and eventual secretion of resistin from adipose cells.
UR - http://www.scopus.com/inward/record.url?scp=0036267020&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036267020&partnerID=8YFLogxK
U2 - 10.2337/diabetes.51.6.1737
DO - 10.2337/diabetes.51.6.1737
M3 - Article
C2 - 12031960
AN - SCOPUS:0036267020
SN - 0012-1797
VL - 51
SP - 1737
EP - 1744
JO - Diabetes
JF - Diabetes
IS - 6
ER -